Spinal Laminoplasty Market Forecasts to 2030 – Global Analysis By Surgery Type (Open Laminoplasty and Minimally Invasive Laminoplasty), By Material (Polyetheretherketone (PEEK) Implants, Titanium Implants and Tantalum Implants), Vertebral Position, Techno

Spinal Laminoplasty Market Forecasts to 2030 – Global Analysis By Surgery Type (Open Laminoplasty and Minimally Invasive Laminoplasty), By Material (Polyetheretherketone (PEEK) Implants, Titanium Implants and Tantalum Implants), Vertebral Position, Technology, End User and By Geography

According to Stratistics MRC, the Global Spinal Laminoplasty Market is accounted for $5.98 billion in 2023 and is expected to reach $8.71 billion by 2030 growing at a CAGR of 5.5% during the forecast period. Spinal laminoplasty is a surgical procedure used to treat cervical spinal stenosis by enlarging the spinal canal. It involves creating a hinge on one side of the lamina bone and lifting it, allowing decompression of the spinal cord and nerves. This technique preserves spinal stability while providing relief from symptoms such as pain, numbness, and weakness caused by spinal cord compression.

According to a study published in 2021, approximately 500,000 lumbar spine surgeries were performed in the US.

Market Dynamics:

Driver:

Rising prevalence of spinal stenosis

The rising prevalence of spinal stenosis serves as a significant driver in the spinal laminoplasty market. Spinal stenosis, characterized by the narrowing of the spinal canal, leads to compression of the spinal cord and nerves, causing symptoms like pain, numbness, and weakness. Spinal laminoplasty, a surgical procedure aimed at alleviating spinal cord compression, is increasingly adopted as a treatment option for patients with spinal stenosis. This growing patient population drives demand for laminoplasty procedures and related medical devices, fostering market growth.

Restraint:

High cost of procedures

Patients may face financial barriers to accessing treatment, especially in regions with limited healthcare coverage or high out-of-pocket expenses. Additionally, healthcare providers and facilities may experience challenges in reimbursement and pricing negotiations with payers, impacting their ability to offer affordable services. This cost barrier can deter patients from seeking or completing treatment, thereby limiting the overall market potential for spinal laminoplasty procedures.

Opportunity:

Growing awareness of minimally invasive surgeries

Minimally invasive techniques offer advantages such as reduced post-operative pain, shorter hospital stays, and quicker recovery times compared to traditional open surgeries. As patients become more informed about these benefits, there is a rising demand for minimally invasive spinal procedures, including laminoplasty. This trend drives innovation in surgical technologies and techniques, encouraging healthcare providers to adopt minimally invasive approaches and expand their offerings in the spinal laminoplasty market.

Threat:

Complications associated with spinal laminoplasty

The complications associated with spinal laminoplasty pose a significant threat to the market. These complications, including nerve damage, infection, and instability of the spine, can lead to post-operative complications and patient dissatisfaction. Moreover, the risk of reoperation and long-term complications may deter both patients and healthcare providers from choosing laminoplasty as a treatment option. Additionally, negative outcomes can damage the reputation of the procedure and decrease its adoption rate, impacting the growth prospects of the spinal laminoplasty market.

Covid-19 Impact

The COVID-19 pandemic has impacted the spinal laminoplasty market by disrupting elective surgeries and reducing patient access to healthcare facilities. Lockdown measures and reallocation of resources towards managing the pandemic led to the postponement of non-urgent spinal procedures. This resulted in decreased procedural volumes and revenue for healthcare providers offering spinal laminoplasty services.

The open laminoplasty segment is expected to be the largest during the forecast period

Over the forecast period, the open laminoplasty segment is anticipated to dominate the spinal laminoplasty market. This is attributed to the long-standing use of and established surgical techniques associated with open laminoplasty procedures. Additionally, open laminoplasty allows for greater visualization and decompression of the spinal cord compared to minimally invasive techniques. Furthermore, the preference for familiar and proven surgical methods by surgeons contributes to the sustained demand for open laminoplasty procedures in spinal surgery.

The 3D printing segment is expected to have the highest CAGR during the forecast period

The 3D printing segment is projected to witness the highest growth rate in the spinal laminoplasty market during the forecast period. This growth is driven by advancements in 3D printing technology, enabling the production of patient-specific implants and surgical instruments tailored to individual anatomies. Additionally, 3D printing offers benefits such as improved surgical precision, faster production times, and reduced costs. These factors contribute to the increasing adoption of 3D printing in spinal laminoplasty procedures, fueling market growth.

Region with largest share:

North America is positioned to secure the largest market share in the spinal laminoplasty market due to the region's advanced healthcare infrastructure, high prevalence of spinal disorders, and early adoption of innovative medical technologies. Additionally, robust reimbursement policies and favorable healthcare regulations support the uptake of spinal procedures in North America. Moreover, the presence of leading medical device companies and renowned healthcare institutions further strengthens the region's dominance in the spinal laminoplasty market.

Region with highest CAGR:

The Asia-Pacific region is poised for rapid growth in the spinal laminoplasty market owing to the increasing prevalence of spinal disorders, rising healthcare expenditures, and expanding access to advanced medical facilities. Additionally, improving healthcare infrastructure and growing awareness about spinal health drive demand for surgical interventions like laminoplasty. Moreover, the region's large population and aging demographics create a substantial patient pool, contributing to the growth opportunities for spinal procedures in the Asia-Pacific market.

Key players in the market

Some of the key players in Spinal Laminoplasty Market include Aesculap, Inc., Alphatec Holdings, Inc., Amedica Corporation, Captiva Spine, CoreLink, LLC, DePuy Synthes, Globus Medical Inc., Joimax GmbH, Medtronic plc, Nexxt Spine LLC, NuVasive, Inc., Orthofix Medical Inc., Osseus Fusion Systems, RTI Surgical Holdings, Inc., Spinal Elements, Inc., Spineart, Stryker Corporation, Ulrich Medical and Zimmer Biomet Holdings, Inc.

Key Developments:

In October 2023, Johnson & Johnson MedTech announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its TriLEAP™ Lower Extremity Anatomic Plating System, a comprehensive yet modular, procedure-specific system designed to meet the complex needs of orthopaedic surgeons, doctors of podiatric medicine, and foot and ankle specialists. The TriLEAP™ System provides a diverse offering of contoured and conventional plates that can accommodate multiple screw diameters, and instruments that can be used during the reduction, internal fixation and fusion of bones and bone fragments.

In September 2023, Globus Medical, Inc., a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc. The combined company will provide surgeons and patients with one of the most comprehensive offerings of musculoskeletal procedural solutions and enabling technologies to impact the care continuum.

In December 2022, Captiva Spine announces an exclusive strategic partnership with REMEX Medical for Spine Navigation and Robotics, adding to their expanding product portfolio. For underserved hospitals and Ambulatory Surgery Centers (ASCs) throughout the U.S., this technology will serve as a platform to expand the company’s products and services with enhanced enabling technology to support MIS technology. Specifically, Captiva Spine will be starting with their CapLOX Pedicle Screws, TowerLOX-EXT MIS Extended Tab Pedicle Screws, and TransFasten Posterior SI joint fusion system.

Survey Types Covered:
• Open Laminoplasty
• Minimally Invasive Laminoplasty

Materials Covered:
• Polyetheretherketone (PEEK) Implants
• Titanium Implants
• Tantalum Implants

Vertebral Positions Covered:
• Cervical Laminoplasty
• Lumbar Laminoplasty
• Sacral Laminoplasty
• Thoracic Laminoplasty
• Other Vertebral Positions

Technologies Covered:
• 3D Printing
• Biologics
• High-Speed Drills
• Intraoperative Neuromonitoring
• Robotics
• Surgical Navigation Systems
• Ultrasonic Bone Scalpel
• Other Technologies

End Users Covered:
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances